These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 22683129)

  • 21. Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications).
    Young RJ; Macintyre CC; Martyn CN; Prescott RJ; Ewing DJ; Smith AF; Viberti G; Clarke BF
    Diabetologia; 1986 Mar; 29(3):156-61. PubMed ID: 3699306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy.
    van Duinkerken E; Schoonheim MM; Steenwijk MD; Klein M; IJzerman RG; Moll AC; Heymans MW; Snoek FJ; Barkhof F; Diamant M
    Diabetes Care; 2014 Sep; 37(9):2483-90. PubMed ID: 24973436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive Function Deficits Associated With Long-Duration Type 1 Diabetes and Vascular Complications.
    Musen G; Tinsley LJ; Marcinkowski KA; Pober D; Sun JK; Khatri M; Huynh R; Lu A; King GL; Keenan HA
    Diabetes Care; 2018 Aug; 41(8):1749-1756. PubMed ID: 29871904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in cognitive function in patients with diabetes mellitus].
    Szémán B; Nagy G; Varga T; Veres-Székely A; Sasvári M; Fitala D; Szollosi A; Katonai R; Kotyuk E; Somogyi A
    Orv Hetil; 2012 Mar; 153(9):323-9. PubMed ID: 22348847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study.
    Urbina EM; Isom S; Bell RA; Bowlby DA; D'Agostino R; Daniels SR; Dolan LM; Imperatore G; Marcovina SM; Merchant AT; Reynolds K; Shah AS; Wadwa RP; Dabelea D;
    J Am Heart Assoc; 2019 Jul; 8(13):e010150. PubMed ID: 31213111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial: response to Cukierman-Yaffe et al.
    Abbatecola AM; Paolisso G
    Diabetes Care; 2009 Aug; 32(8):e102; author reply e103. PubMed ID: 19638518
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin neuritis and diabetic cachectic neuropathy: a review.
    Knopp M; Srikantha M; Rajabally YA
    Curr Diabetes Rev; 2013 May; 9(3):267-74. PubMed ID: 23506377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The study of development and progression of long-term complications in type I diabetes].
    Araki E; Matsumura T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurocognitive consequences of diabetes.
    Ryan CM; van Duinkerken E; Rosano C
    Am Psychol; 2016 Oct; 71(7):563-576. PubMed ID: 27690485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A MODERN APPROACH TO THE TREATMENT OF DIABETIC POLYNEUROPATHY].
    Romanova IP; Kazakov AV; Oleynikova SP; Chernyavskaya IV; Dorosh EG
    Lik Sprava; 2015; (7-8):95-8. PubMed ID: 27491158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating diabetes today with gliclazide MR: a matter of numbers.
    Avogaro A
    Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():14-9. PubMed ID: 22118706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive disorders in diabetic patients.
    Koekkoek PS; Rutten GE; Biessels GJ
    Handb Clin Neurol; 2014; 126():145-66. PubMed ID: 25410220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes.
    Cox DJ; Kovatchev BP; Gonder-Frederick LA; Summers KH; McCall A; Grimm KJ; Clarke WL
    Diabetes Care; 2005 Jan; 28(1):71-7. PubMed ID: 15616236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant functional connectivity of default-mode network in type 2 diabetes patients.
    Cui Y; Jiao Y; Chen HJ; Ding J; Luo B; Peng CY; Ju SH; Teng GJ
    Eur Radiol; 2015 Nov; 25(11):3238-46. PubMed ID: 25903712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olfactory dysfunction in diabetes mellitus.
    Weinstock RS; Wright HN; Smith DU
    Physiol Behav; 1993 Jan; 53(1):17-21. PubMed ID: 8434058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between adult neuropsychological profiles and diabetic patients' glycemic control.
    Zihl J; Schaaf L; Zillmer EA
    Appl Neuropsychol; 2010 Jan; 17(1):44-51. PubMed ID: 20146121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy.
    Hepburn DA; MacLeod KM; Frier BM
    Diabet Med; 1993 Dec; 10(10):940-9. PubMed ID: 8306590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular depression in older people with diabetes.
    Bruce DG; Casey G; Davis WA; Starkstein SE; Clarnette RC; Foster JK; Ives FJ; Almeida OP; Davis TM
    Diabetologia; 2006 Dec; 49(12):2828-36. PubMed ID: 17039347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of streptozotocin-induced diabetic rats with alogliptin: effect on vascular and neural complications.
    Davidson EP; Coppey LJ; Dake B; Yorek MA
    Exp Diabetes Res; 2011; 2011():810469. PubMed ID: 21822422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review.
    Geijselaers SLC; Sep SJS; Stehouwer CDA; Biessels GJ
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):75-89. PubMed ID: 25163604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.